Saol Therapeutics Secures Up to $115 Million Milestone-Based Financing from Oaktree Capital Management

Holland & Knight has advised Saol Therapeutics. Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, has entered into a definitive agreement through which funds managed by…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here